BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 8808701)

  • 1. Studies of X-irradiated bladder cancer cell lines showing differences in p53 status: absence of a p53-dependent cell cycle checkpoint pathway.
    Ribeiro JC; Hanley JR; Russell PJ
    Oncogene; 1996 Sep; 13(6):1269-78. PubMed ID: 8808701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytogenetic damage and the radiation-induced G1-phase checkpoint.
    Gupta N; Vij R; Haas-Kogan DA; Israel MA; Deen DF; Morgan WF
    Radiat Res; 1996 Mar; 145(3):289-98. PubMed ID: 8927696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cell cycle regulation after exposure to ionizing radiation].
    Teyssier F; Bay JO; Dionet C; Verrelle P
    Bull Cancer; 1999 Apr; 86(4):345-57. PubMed ID: 10341340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissociation between cell cycle arrest and apoptosis can occur in Li-Fraumeni cells heterozygous for p53 gene mutations.
    Delia D; Goi K; Mizutani S; Yamada T; Aiello A; Fontanella E; Lamorte G; Iwata S; Ishioka C; Krajewski S; Reed JC; Pierotti MA
    Oncogene; 1997 May; 14(18):2137-47. PubMed ID: 9174049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of p53 in G2/M cell cycle arrest and apoptosis in response to gamma-irradiation in ovarian carcinoma cell lines.
    Concin N; Stimpfl M; Zeillinger C; Wolff U; Hefler L; Sedlak J; Leodolter S; Zeillinger R
    Int J Oncol; 2003 Jan; 22(1):51-7. PubMed ID: 12469184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between radiation response and p53 status in human bladder cancer cells.
    Ribeiro JC; Barnetson AR; Fisher RJ; Mameghan H; Russell PJ
    Int J Radiat Biol; 1997 Jul; 72(1):11-20. PubMed ID: 9246190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 modulates base excision repair activity in a cell cycle-specific manner after genotoxic stress.
    Offer H; Zurer I; Banfalvi G; Reha'k M; Falcovitz A; Milyavsky M; Goldfinger N; Rotter V
    Cancer Res; 2001 Jan; 61(1):88-96. PubMed ID: 11196204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response of Ewing tumor cells to forced and activated p53 expression.
    Kovar H; Pospisilova S; Jug G; Printz D; Gadner H
    Oncogene; 2003 May; 22(21):3193-204. PubMed ID: 12761489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different combinations of genetic/epigenetic alterations inactivate the p53 and pRb pathways in invasive human bladder cancers.
    Sarkar S; Jülicher KP; Burger MS; Della Valle V; Larsen CJ; Yeager TR; Grossman TB; Nickells RW; Protzel C; Jarrard DF; Reznikoff CA
    Cancer Res; 2000 Jul; 60(14):3862-71. PubMed ID: 10919661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. G2/M checkpoint is p53-dependent and independent after irradiation in five human sarcoma cell lines.
    Bache M; Dunst J; Würl P; Fröde D; Meye A; Schmidt H; Rath FW; Taubert H
    Anticancer Res; 1999; 19(3A):1827-32. PubMed ID: 10470122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of retinoblastoma gene product in p53-mediated DNA damage response.
    Smith ML; Zhan Q; Bae I; Fornace AJ
    Exp Cell Res; 1994 Dec; 215(2):386-9. PubMed ID: 7982477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 checkpoint-defective cells are sensitive to X rays, but not hypoxia.
    Denko NC; Green SL; Edwards D; Giaccia AJ
    Exp Cell Res; 2000 Jul; 258(1):82-91. PubMed ID: 10912790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the p53 tumor suppressor gene in the tumorigenicity of Burkitt's lymphoma cells.
    Cherney BW; Bhatia KG; Sgadari C; Gutierrez MI; Mostowski H; Pike SE; Gupta G; Magrath IT; Tosato G
    Cancer Res; 1997 Jun; 57(12):2508-15. PubMed ID: 9192833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Explaining differences in sensitivity to killing by ionizing radiation between human lymphoid cell lines.
    Aldridge DR; Radford IR
    Cancer Res; 1998 Jul; 58(13):2817-24. PubMed ID: 9661896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The p53 tumor suppressor gene and nuclear protein: basic science review and relevance in the management of bladder cancer.
    Smith ND; Rubenstein JN; Eggener SE; Kozlowski JM
    J Urol; 2003 Apr; 169(4):1219-28. PubMed ID: 12629332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of tumor cell growth by RTP/rit42 and its responsiveness to p53 and DNA damage.
    Kurdistani SK; Arizti P; Reimer CL; Sugrue MM; Aaronson SA; Lee SW
    Cancer Res; 1998 Oct; 58(19):4439-44. PubMed ID: 9766676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relaxed cell-cycle arrests and propagation of unrepaired chromosomal damage in cancer cell lines with wild-type p53.
    Olivier M; Bautista S; Vallès H; Theillet C
    Mol Carcinog; 1998 Sep; 23(1):1-12. PubMed ID: 9766432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adriamycin induced G2/M cell cycle arrest in transitional cell cancer cells with wt p53 and p21(WAF1/CIP1) genes.
    Bilim V; Kawasaki T; Takahashi K; Tomita Y
    J Exp Clin Cancer Res; 2000 Dec; 19(4):483-8. PubMed ID: 11277327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of normal G1 checkpoint control is an early step in carcinogenesis, independent of p53 status.
    Syljuåsen RG; Krolewski B; Little JB
    Cancer Res; 1999 Mar; 59(5):1008-14. PubMed ID: 10070956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of radiation-induced G2 delay potentiates cell death by apoptosis and/or the induction of giant cells in colorectal tumor cells with disrupted p53 function.
    Bracey TS; Williams AC; Paraskeva C
    Clin Cancer Res; 1997 Aug; 3(8):1371-81. PubMed ID: 9815821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.